These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21447010)

  • 21. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y; Loizidou M; Seifalian AM
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends.
    Sohail MF; Rehman M; Sarwar HS; Naveed S; Salman O; Bukhari NI; Hussain I; Webster TJ; Shahnaz G
    Int J Nanomedicine; 2018; 13():3145-3161. PubMed ID: 29922053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soft matter assemblies as nanomedicine platforms for cancer chemotherapy: a journey from market products towards novel approaches.
    Jäger E; Giacomelli FC
    Curr Top Med Chem; 2015; 15(4):328-44. PubMed ID: 25633209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy.
    Palmerston Mendes L; Pan J; Torchilin VP
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28832535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
    Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
    Wakaskar RR
    J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
    Kaur M; Nagpal M; Aggarwal G
    Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The benefits and challenges associated with the use of drug delivery systems in cancer therapy.
    Cukierman E; Khan DR
    Biochem Pharmacol; 2010 Sep; 80(5):762-70. PubMed ID: 20417189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimuli-responsive polymeric nanoparticles for nanomedicine.
    Crucho CI
    ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle-Delivered Chemotherapy: Old Drugs in New Packages.
    Lee MS; Dees EC; Wang AZ
    Oncology (Williston Park); 2017 Mar; 31(3):198-208. PubMed ID: 28299757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current trends and future perspectives of nanomedicine for the management of colon cancer.
    Wahab S; Alshahrani MY; Ahmad MF; Abbas H
    Eur J Pharmacol; 2021 Nov; 910():174464. PubMed ID: 34474029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor-targeted nanocarriers for therapeutic delivery to cancer.
    Yu B; Tai HC; Xue W; Lee LJ; Lee RJ
    Mol Membr Biol; 2010 Oct; 27(7):286-98. PubMed ID: 21028937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimuli-responsive polymersomes for cancer therapy.
    Thambi T; Park JH; Lee DS
    Biomater Sci; 2016 Jan; 4(1):55-69. PubMed ID: 26456625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes.
    Ahmed SE; Martins AM; Husseini GA
    J Drug Target; 2015 Jan; 23(1):16-42. PubMed ID: 25203857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design considerations for nanotherapeutics in oncology.
    Stylianopoulos T; Jain RK
    Nanomedicine; 2015 Nov; 11(8):1893-907. PubMed ID: 26282377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifunctional micellar nanomedicine for cancer therapy.
    Blanco E; Kessinger CW; Sumer BD; Gao J
    Exp Biol Med (Maywood); 2009 Feb; 234(2):123-31. PubMed ID: 19064945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.